Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP646070.RAV5lMaDRIQY7KLO34ZB-xsF1vpLg5AdrNToV3a7A0vhM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP646070.RAV5lMaDRIQY7KLO34ZB-xsF1vpLg5AdrNToV3a7A0vhM130_assertion type Assertion NP646070.RAV5lMaDRIQY7KLO34ZB-xsF1vpLg5AdrNToV3a7A0vhM130_head.
- NP646070.RAV5lMaDRIQY7KLO34ZB-xsF1vpLg5AdrNToV3a7A0vhM130_assertion description "[For 15-lipoxygenase-1 and cyclooxygenase-2, we did not observe differential expression, but there was a trend for increased steady-state concentrations of cyclooxygenase-1 (P=0.1 for ovarian carcinoma, P=0.011 for metastases) and 5-lipoxygenase (P=0.1 for ovarian carcinoma, P=0.018 for metastases, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646070.RAV5lMaDRIQY7KLO34ZB-xsF1vpLg5AdrNToV3a7A0vhM130_provenance.
- NP646070.RAV5lMaDRIQY7KLO34ZB-xsF1vpLg5AdrNToV3a7A0vhM130_assertion evidence source_evidence_literature NP646070.RAV5lMaDRIQY7KLO34ZB-xsF1vpLg5AdrNToV3a7A0vhM130_provenance.
- NP646070.RAV5lMaDRIQY7KLO34ZB-xsF1vpLg5AdrNToV3a7A0vhM130_assertion SIO_000772 18090132 NP646070.RAV5lMaDRIQY7KLO34ZB-xsF1vpLg5AdrNToV3a7A0vhM130_provenance.
- NP646070.RAV5lMaDRIQY7KLO34ZB-xsF1vpLg5AdrNToV3a7A0vhM130_assertion wasDerivedFrom befree-2016 NP646070.RAV5lMaDRIQY7KLO34ZB-xsF1vpLg5AdrNToV3a7A0vhM130_provenance.
- NP646070.RAV5lMaDRIQY7KLO34ZB-xsF1vpLg5AdrNToV3a7A0vhM130_assertion wasGeneratedBy ECO_0000203 NP646070.RAV5lMaDRIQY7KLO34ZB-xsF1vpLg5AdrNToV3a7A0vhM130_provenance.